Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers

Journal of Clinical Oncology

Volumn 18, Issue 21 SUPPL., 2000, Pages

  Rebbeck, T R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; CANCER PREVENTION; CANCER RISK; HUMAN; OVARIECTOMY; OVARY CANCER; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW;

BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; OVARIECTOMY; TRANSCRIPTION FACTORS;

EID: 0034331055     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families
2. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in BC families: The BC Linkage Consortium
3. Risks of cancer in BRCAl-mutation carriers: Breast Cancer Linkage Consortium
4. The risk of cancer associated with specific variants of BRCA 1 and BRCA2 among Ashkenazi Jews
5. Recommendations for follow-up care of individuals with an inherited predisposition to cancer
6. Decision analysis: Effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA 1 or BRCA2 mutations
7. Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients
8. Oral contraceptive use reduces the risk of hereditary ovarian cancer
9. Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women?
10. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
11. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
12. Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomised trial among hysterectomized women
13. Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer
14. Prophylactic oophorectomy in inherited breast/ovarian cancer families
15. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer: A report of the Gilda Radner Family Ovarian Cancer Registry
16. Reduction in breast cancer risk following bilateral prophylactic oophorectomy in BRCA 1 mutation carriers